Allison Dorval, CFO: Verve Therapeutics VERV Sell · Filed 24/12/03

Trade details

Type: Insider sale
Amount: $3,130.2
Shares · price: 555 sh · $5.64 a share
Held after: 5,380 sh
Stock: Verve Therapeutics VERV
Person: Allison DorvalCFO
Trade date: 24/12/02
Filed: 24/12/03
Days to filing: 1 days

Sold 9.4% of holdings

Share of holding sold: 9.4%

Verve Therapeutics trades, last 26 weeks

What else happened in Verve Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/02~25/01/01

Allison Dorval's recent trades

Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$83.6K
11,610 sh
$83.6K
Filed 06/15
Traded 06/12
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$84.3K
11,610 sh
$84.3K
Filed 06/12
Traded 06/12
Allison DorvalDirector
Sell10b5-1 planPuma Biotechnology
Sell10b5-1 plan
Puma Biotechnology
PBYI
$39.5K
11,610 sh
$39.5K
Filed 25/06/17
Traded 25/06/13
Allison DorvalDirector
Planned sale10b5-1 planPuma Biotechnology
Planned sale10b5-1 plan
Puma Biotechnology
PBYI
$39.4K
11,610 sh
$39.4K
Filed 25/06/13
Traded 25/06/13
Allison DorvalCFO
Sell10b5-1 planVerve Therapeutics
Sell10b5-1 plan
Verve Therapeutics
VERV
$13.9K
3,350 sh
$13.9K
Filed 25/04/03
Traded 25/04/02